Clocinizine hydrochloride
- Level
- Commodity
- Parent
- 51313100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313117This classification denotes a histamine-1 receptor antagonist with the molecular formula C26H27CLN2.2CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AE8KM1QU3Q. European Medicines Agency schedules clocinizine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01350MIG. The term clocinizine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule clocinizine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, CLOCINIZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clocinizine hydrochloride bears US NLM identifiers UMLS ID C3273574 and NCI Concept Code C97696. SMILES: C1CCC(CC1)/C=C/CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.
Same parent
Under 51313100 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.